OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden...
FORM 6-K SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Report of Foreign Private Issuer Pursuant to Rule...
TORONTO, Jan. 8 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life...
KING OF PRUSSIA, PA, Jan. 7 /PRNewswire-FirstCall/ -- MDS Pharma Services, a leading provider of innovative drug discovery and development...
TORONTO, Dec. 17 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider of products and services to the global life...
Plans Non-Cash Write-Down for MAPLE Asset and MDS Pharma Services Goodwill TORONTO, Dec. 10 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE:...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 SCHEDULE 13D THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No...
John T. Mayberry Decides to Step Down as Chairman TORONTO, Nov. 19 /PRNewswire-FirstCall/ -- MDS Inc. (TSX: MDS; NYSE: MDZ), a leading provider...
OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2009 Estimated average burden hours per response………...
NEW YORK, Oct. 30 /PRNewswire/ -- MDS Inc. 2700 Matheson Blvd. East Suite 300, West Tower Mississauga, Ontario Canada L4W 4V9 MDS...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.